BN
Bionik Laboratories Corp.
BNKL · OTC
$0.00 +0.00% (+$0.00)
Market Cap $1.25K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/S 0.00x
PEG N/A
P/E N/A
Growth
0 /100
Declining Rev. growth 5.71%
Book val. growth N/A
EPS growth N/A
Profitability
20 /100
Weak Op. margin 267.29%
Gross margin 54.83%
FCF margin 187.64%
Quality
10 /100
Poor Asset turnover 0.54x
ROIC 448.84%
ROA 147.11%
Debt
21 /100
High Int. coverage -45.16x
Current ratio 1.20x
Debt/Assets N/A
Stability
31 /100
Unstable EPS volatility 13.71%
Beta 9.36x
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre BNKL
Online
Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Richard Paul Russo Jr.
Employees
12
Headquarters
Watertown